Riskpilot← Back to searchSign inGet full accessMedicate Bemanning AB
ABBankruptOrg 5590501689General medical practice activities · NACE 8621Est. 20161 employees
Revenue 2022
SEK 1,3M
-9% vs 2021
EBITDA margin
15.1%
+1613% vs 2021
Equity ratio
75.7%
Financial strength
Net profit 2022
SEK 64K
+155% vs 2021
| Revenue | SEK 1,3M | -9% |
| EBITDA | SEK 197K | +1613% |
| Net profit | SEK 64K | +155% |
| Total assets | SEK 1,1M | +52% |
| Equity | SEK 832K | +8% |
| Employees | 1 | — |
Legal name
Medicate Bemanning AB
Org number
5590501689
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
4 februari 2016
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Aktiebolaget ska bedriva läkar- och sjukskötersketjänster samt bedriva därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenue | 2 329 | 2 819 | 2 157 | 1 422 | 1 299 |
| Staff expenses | — | — | — | — | −694 |
| EBITDA | 296 | 448 | 392 | −13 | 197 |
| Depreciation & amort. | −68 | −102 | −161 | −101 | −109 |
| EBIT | 228 | 346 | 231 | −114 | 87 |
| Net financials | — | −2 | −29 | −2 | −7 |
| Profit before tax | 228 | 344 | 202 | −115 | 80 |
| Tax | −50 | −74 | −44 | −0 | −17 |
| Net profit | 178 | 270 | 158 | −115 | 64 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Total assets | 977 | 1 169 | 1 363 | 722 | 1 099 |
| Equity | 456 | 726 | 884 | 768 | 832 |
| Long-term debt | 378 | 262 | 395 | 2 | 0 |
| Short-term debt | 143 | 181 | 84 | 48 | 267 |
| Total debt | 521 | 443 | 479 | 50 | 267 |
EBITDA margin
15.1%
This company
15.8%
Market median
+4% vs market
20182022
Equity ratio
75.7%
This company
38.2%
Market median
+98% vs market
20182022
Return on equity
7.6%
This company
18.4%
Market median
-59% vs market
20182022
Net profit margin
4.9%
This company
8.1%
Market median
-40% vs market
20182022
Asset turnover
1.18×
This company
1.12×
Market median
+5% vs market
20182022
Debt / equity
0.32×
This company
0.62×
Market median
+48% vs market
20182022
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2021 | |
| Former (1) | ||
| Board of Directors | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medicate Bemanning AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Emir Nuredini | Board of Directors | 0 companies |
| Imer Nuredini | Board of Directors | 0 companies |
| Xhevrije Nuredini | Deputy Board Member | 0 companies |